Boston – Akili Interactive Labs, whose parent company is PureTech, has partnered with Delivering Scientific Innovations for Autism (DELSIA) a not-for-profit subsidiary of Autism Speaks, to fund a study to test Akili’s new app Project:EVO
Akili COO Eddie Martucci told Mobile Health News.
“We are very excited to have the involvement and backing of such an excellent organization that believes in our vision: validated medical products that also have a fun user experience.”
Project:EVO asses and treats cognitive issues by having the player move a cultural-neutral yet relatable alien through a course. The alien moves by the player tilting the tablet, or smartphone back and forth. Players must also get rid of targets by tapping the screen. The high resolution game tracks players actions and movements every 30 milliseconds to adapt to them.
“Our products combine the high engagement and high-resolution data of the tech industry with the strong scientific underpinning of the medical industry. We are excited to advance our products further into the clinic and into the market,”
Martucci told Mobile Health News. The app is not available in app stores yet because they want FDA approval first.
Recruitment for the study will begin at the end of the year. The study will be have a placebo group and be completely randomized and double-blind.
Source:Aditi Pai on the MobiHealthNews website: Akili, Autism Speaks partner to study mobile game’s efficacy